Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Kymab

Biotech & Life Sciences · Babraham, United Kingdom · Founded 2010 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$1–10M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

7 investors on Kymab's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Wellcome Trust
Series B+ 6 investors entered at this stage
Woodford Investment Management
Malin Corporation
Wellcome Trust Sanger Institute
ORI Capital
Bill & Melinda Gates Foundation
Hepalink

Global footprint

Where Kymab has talent and traffic

Web traffic by country
20 monthly visits
across markets
🇬🇧 United Kingdom3000%
Top 1 markets shown

See Kymab on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo